Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Centre Hospitalier Regional Universitaire De Tours has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, HERNANDEZ, JACKSON J, who holds the 1 busiest examiner pending action for the institution. The prosecution is situated within 1 distinct art unit, showing a narrow administrative scope for the current application.
With 1 pending office action, the institution's current patenting efforts are focused on a single point of review. Success in the Biotechnology & Pharmaceuticals technology area is currently tied to the specific requirements and interpretations of HERNANDEZ, JACKSON J, making the examiner's individual history a critical factor. The 1 distinct examiner involved is the sole arbiter of the institution's active patent claims.
The concentration of work in 1 distinct art unit allows the applicant to focus on the specific standards of that unit. Because there is only 1 busiest examiner pending action, the institution can dedicate its legal resources to addressing the specific prior art cited by HERNANDEZ, JACKSON J. This focused approach is common for specialized research institutions with a targeted intellectual property strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HERNANDEZ, JACKSON J | 1 | 50.7% | +39.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294636 | ANTIBODY-DRUG CONJUGATES | HERNANDEZ, JACKSON J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294636 | ANTIBODY-DRUG CONJUGATES | HERNANDEZ, JACKSON J | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18294636 | ANTIBODY-DRUG CONJUGATES | HERNANDEZ, JACKSON J | 1627 | §103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCentre Hospitalier Regional Universitaire De Tours has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jackson J Hernandez has the most, with 1 of Centre Hospitalier Regional Universitaire De Tours's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
